Prime Medicine (PRME) Appoints Svetlana Makhni as Chief Financial Officer

Prime Medicine (PRME) Appoints Svetlana Makhni as Chief Financial Officer

Summary

On April 15, 2026, Prime Medicine, Inc. (NASDAQ:PRME) announced the appointment of Svetlana Makhni as Chief Financial Officer.

Description

On April 15, 2026, Prime Medicine, Inc. (NASDAQ:PRME) announced the appointment of Svetlana Makhni as Chief Financial Officer.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage